Drug intelligence / Profile preview

omeprazole

Development stage
Approved
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Omeprazole is a small molecule pharmaceutical drug classified as a proton pump inhibitor (PPI). It is used to treat conditions involving excessive stomach acid production such as gastroesophageal reflux disease (GERD), gastric and duodenal ulcers, erosive esophagitis, Zollinger-Ellison syndrome (a rare condition with excess acid due to tumors), and for the eradication of Helicobacter pylori infection in combination with antibiotics. Omeprazole works by irreversibly inhibiting the H+/K+-ATPase enzyme system ("proton pump") on gastric parietal cells—the final step in gastric acid secretion—thereby reducing both basal and stimulated stomach acid output. The drug is available both over-the-counter and by prescription in various oral formulations.

Brand names
PrilosecPrilosec OTCLosecLosec MUPSPyrocalmOmesecZegerid
Other names
FIRST OmeprazoleOmeprazole + SyrSpend SF Alka
02

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on omeprazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omeprazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call